Plasma-derived product · developed by Orphan Therapies Llc
Albumin is the main protein in blood plasma, a globular protein that binds a wide variety of ligands. It is given intravenously in studies of patients with cirrhosis, ascites, hepatic encephalopathy and postural tachycardia syndrome.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT06812390 | Phase 2 | Cirrhosis | Recruiting | GRFS |
| NCT06052176 | Phase 2 | Cirrhosis | Active not recruiting | GRFS |
| NCT03919773 | Phase 1/2 | Postural Tachycardia Syndrome | Completed | GRFS |
| NCT03585257 | Phase 2 | Cirrhosis | Completed | GRFS |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Ascites HepaticCirrhosisCovert Hepatic EncephalopathyHepatic EncephalopathyMinimal Hepatic EncephalopathyPostural Tachycardia Syndrome
Updated Oct 11, 2026.